• 1
    Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2012; 1:CD008965.
  • 2
    Hsu J, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2012; 156:512524.
  • 3
    Guyatt GH, et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924926.
  • 4
    Chemaly RF, Torres HA, Aguilera EA, et al. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis 2007; 44:964967.
  • 5
    Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010; 182:4148.
  • 6
    Hien ND, Ha NH, Van NT, et al. Human infection with highly pathogenic avian influenza virus (H5N1) in Northern Vietnam, 2004–2005. Emerg Infect Dis 2009; 15:1923.
  • 7
    Huang YC, Li WC, Tsao KC, Huang CG, Chiu CH, Lin TY. Influenza-associated central nervous system dysfunction in Taiwanese children: clinical characteristics and outcomes with and without administration of oseltamivir. Pediatr Infect Dis J 2009; 28:647648.
  • 8
    Li IW, Hung IF, To KK, et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137:759768.
  • 9
    Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza a (H5N1) infection in vietnam: 2004–2006. Clin Infect Dis 2009; 48:16391646.
  • 10
    McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:15681575.
  • 11
    Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:15171525.
  • 12
    Xi X, Xu Y, Jiang L, Li A, Duan J, Du B. Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect Dis 2009; 10:256.
  • 13
    Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS ONE 2009; 4:e6051.
  • 14
    McGeer A, Green K, Drews S et al. Epidemiology of influenza illness requiring intensive care unit admission in Toronto, Canada. 19th European Congress of Clinical Microbiology and Infectious Diseases [conference abstract]. 2009; vol 15:S26.
  • 15
    Blumentals WA, Song X. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons. MedGenMed 2007; 9:23.
  • 16
    Dharan NJ, Gubareva LV, Klimov AI, Fiare AE, Bresee JS, Fry AM. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal influenza A (H1N1) infection during the 2007–2008 influenza season in the United States. Clin Infect Dis [Letter]. 2010; 50:621622.
  • 17
    Nordstrom BL, Sung I, Suter P, Szneke P. Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Curr Med Res Opin 2005; 21:761768.
  • 18
    Piedra PA, Schulman KL, Blumentals WA. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics 2009; 124:170178.
  • 19
    Imamura T, Hosoya M, Oonishi N, et al. The study on efficacy of oseltamivir for influenza A in children. Kansenshogaku Zasshi 2003; 77:971976.
  • 20
    Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 2008; 56:5157.
  • 21
    Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003–2004 and 2004–2005 influenza seasons. Clin Infect Dis 2006; 43:439444.
  • 22
    Sato M, Saito R, Sato I, et al. Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City. Japan. Tohoku J Exp Med 2008; 214:113120.
  • 23
    Sugaya N, Mitamura K, Yamazaki M, et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007; 44:197202.
  • 24
    Sugaya N, Tamura D, Yamazaki M, et al. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis 2008; 47:339345.
  • 25
    Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L. Use of Oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes 2009; 2:108115.
  • 26
    Peters PH Jr, Moscona A, Schulman KL, Barr CE. Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000–2005. MedGenMed 2008; 10:131.
  • 27
    Machado CM, Vilas Boas LS, Mendes AVA, et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31:695700.
  • 28
    Saito R, Sato I, Suzuki Y, et al. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation. Pediatr Infect Dis J 2010; 29:898904.
  • 29
    Cole JA, Loughlin JE, Ajene AN, Rosenberg DM, Cook SF, Walker AM. The effect of zanamivir treatment on influenza complications: a retrospective cohort study. Clin Ther 2002; 24:18241839.
  • 30
    Kawai N, Ikematsu H, Iwaki N, et al. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation. J Infect 2009; 59:207212.
  • 31
    Komiya N, Gu Y, Kamiya H et al. Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009. Euro Surveill. 2009; 14.
  • 32
    Chien YS, Su CP, Tsai HT, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010; 60:168174.
  • 33
    Hien TT, Boni MF, Bryant JE, et al. Early pandemic influenza (2009 H1N1) in Ho Chi Minh city, Vietnam: a clinical virological and epidemiological analysis. PLoS Med 2010; 7:e1000277.
  • 34
    Lee N, Chan PKS, Hui DSC, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492500.
  • 35
    Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50:963969.
  • 36
    Centers for Disease Control and Prevention (CDC). Patients hospitalized with 2009 pandemic influenza A (H1N1) – New York City, May 2009. MMWR Morb Mortal Wkly Rep 2009; 2010(58):14361440.
  • 37
    Lee N, Choi KW, Chan PKS, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65:510515.
  • 38
    Subramony H, Lai FY, Ang LW, Cutter JL, Lim PL, James L. An epidemiological study of 1348 cases of pandemic H1N1 influenza admitted to Singapore Hospitals from July to September 2009. Ann Acad Med Singapore 2010; 39:283288.
  • 39
    Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010; 341:c4779.
  • 40
    Kawai N, Ikematsu H, Iwaki N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from japan of the 2002–2003 influenza season. Clin Infect Dis 2005; 40:13091316.
  • 41
    Gagarinova VM, Shadrin AS, Kubar OI, Kustikova IG, Araslanova II. Organization and evaluation of the effectiveness of emergency prophylaxis and early treatment of influenza with remantadine in serevodvinsk. Zh Mikrobiol Epidemiol Immunobiol. 1983;3: 6063.
  • 42
    Shadrin AS, Araslanova II, Dekterev AN, Gagarinova VM, Tamarkina KN. Organization and the results of the early ambulatory treatment of influenza patients. Sov Med 1980; 9:103104.